Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Novartis Ag
Relationship:   10% Owner
City:   Basel Switzerland
State:   V8
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   49,437,478    

Indirect Shares

   22,159,174      
Direct Value   $476,962,014    

Indirect Value

   $317,835,274      
Total Shares   71,596,652      
Total Value   $794,797,288      


Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $12,357,010 Kineta Ord Shs $870,751 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $88,297,326 Q32 Bio Inc $50,470,263 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $6,654,061 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $530,858 Poseida Therapeutics, Inc. $17,665,186 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $160,055,976 Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $12,357,010 Kineta Ord Shs $870,751 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $88,297,326 Q32 Bio Inc $50,470,263 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $6,654,061 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $530,858 Poseida Therapeutics, Inc. $17,665,186 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $160,055,976
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    14    

     Stock price went up :
    0   
    14    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   14.0   
     Percentage Gain/Loss :
     0.0%
 273.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA 10% Owner 0 2006-07-25 4,708,679    Premium*  
            Adhera Therapeutics, Inc ATRX 10% Owner 2011-01-26 2,495,065 0    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2014-08-05 0 2014-08-05 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN 10% Owner 2015-07-15 4,493,458 2014-09-22 0    Premium*  
            Kineta Ord Shs KA 10% Owner 2016-02-17 1,873,791 2016-02-17 0    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE 2018-05-11 2,175,314 2016-04-12 0    Premium*  
            Intellia Therapeutics, Inc. NTLA 10% Owner 2017-12-12 4,129,903 2016-05-11 0    Premium*  
            Q32 Bio Inc QTTB 10% Owner 2018-04-02 1,979,226 2018-04-02 0    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2017-06-19 2,251,457 2016-10-31 0    Premium*  
            Aadi Bioscience, Inc AADI 10% Owner 2017-03-15 0 2019-04-26 4,049,804    Premium*  
            Altimmune, Inc ALT 10% Owner 0 2018-09-12 8,345,145    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 3,948,482 2018-04-23 0    Premium*  
            Aileron Therapeutics Inc ALRN 10% Owner 2019-04-01 2,079,394 2018-07-16 0    Premium*  
            Bicycle Therapeutics Ltd BCYC 10% Owner 2019-05-28 1,769,641 2019-05-28 0    Premium*  
            Galera Therapeutics, Inc. GRTX Former 10% Owner 2020-06-19 2,467,961 2019-11-12 3,543,067    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX 10% Owner 0 2020-06-18 331,221    Premium*  
            Akouos, Inc. AKUS Former 10% Owner 2020-06-30 0 2020-06-30 1,181,258    Premium*  
            Poseida Therapeutics, Inc. PSTX 10% Owner 2020-07-14 5,908,089 2020-07-14 0    Premium*  
            Cellular Biomedicine Group Inc CBMG 10% Owner 2020-08-11 1,458,257 0    Premium*  
            Precision Biosciences Inc DTIL 10% Owner 2022-06-15 12,407,440 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NTLA Intellia Therapeutics, In... 10% Owner   –       –       •   2016-05-11 4 A $0.00 $0 D/D 5,295,881 5,295,881 0 -
NTLA Intellia Therapeutics, In... 10% Owner   –       –       •   2016-05-11 4 B $18.00 $4,999,986 D/D 277,777 5,573,658 2.45 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 B $13.00 $1,099,995 D/D 84,615 2,545,652 2.45 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 A $0.00 $0 D/D 2,398,462 2,461,037 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 S $13.00 $4,407 D/D (339) 62,575 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2016-10-31 4 OE $0.07 $4,404 D/D 62,914 62,914 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-02-22 4 S $21.86 $16,370 D/D (749) 2,544,903 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-02-23 4 S $21.04 $105,160 D/D (4,999) 2,539,904 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-02-24 4 S $20.93 $113,000 D/D (5,398) 2,534,506 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-02-27 4 S $20.96 $1,212,306 D/D (57,844) 2,476,662 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-02-28 4 S $20.86 $163,670 D/D (7,847) 2,468,815 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-03-01 4 S $20.91 $162,658 D/D (7,778) 2,461,037 0 -
NTLA Intellia Therapeutics, In... 10% Owner   –       –       •   2017-03-03 4 A $0.00 $0 D/D 79,245 5,652,903 0 -
AADI Aadi Bioscience, Inc 10% Owner   –       –       •   2017-03-15 3 IO $0.00 $0 I/I 0 5,245,550 -
AADI Aadi Bioscience, Inc 10% Owner   –       –       •   2017-03-15 4 B $5.00 $2,800,000 I/I 560,000 5,805,550 1.5 -
ALT Altimmune, Inc 10% Owner   –       –       •   2017-05-04 3 IO $0.00 $0 I/I 0 1,867,301 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-16 4 S $26.33 $528,725 D/D (20,081) 2,440,956 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-17 4 S $25.51 $574,901 D/D (22,534) 2,418,422 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-18 4 S $25.50 $229,964 D/D (9,019) 2,409,403 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-24 4 S $25.01 $436,364 D/D (17,451) 2,391,952 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-25 4 S $25.00 $1,325 D/D (53) 2,391,899 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-26 4 S $25.14 $133,267 D/D (5,300) 2,386,599 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-31 4 S $23.94 $850,896 D/D (35,539) 2,351,060 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-01 4 S $23.89 $256,176 D/D (10,722) 2,340,338 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-02 4 S $23.47 $348,949 D/D (14,867) 2,325,471 0 -
  152  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us